Alk-Abelló A/S
🇩🇰Denmark
Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-04-04
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 226
- Registration Number
- NCT00310466
- Locations
- 🇩🇪
Charité Klinik für Dermatologie, Venerologie und Allergologie, Berlin, Germany
Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis
- First Posted Date
- 2006-04-04
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 154
- Registration Number
- NCT00310492
- Locations
- 🇩🇪
Medizinische Hochschule Hannover, Klinik für Dermatologie und Venerologie, Hannover, Germany
Tolerability of ALK Grass Tablet in Children
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-04-04
- Last Posted Date
- 2006-05-04
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 32
- Registration Number
- NCT00310453
- Locations
- 🇪🇸
Servicio de Alergia, Hospital del Niño Jesús, Madrid, Spain
Tolerability of Grazax-R in Children
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-03-03
- Last Posted Date
- 2006-05-04
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 50
- Registration Number
- NCT00298701
- Locations
- 🇩🇪
Tangstedter Landstrasse 77, Hamburg, Germany
Assessment of Grazax® Treatment Compliance
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2008-09-30
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 500
- Registration Number
- NCT00293046
- Locations
- 🇦🇹
Allgergie - Ambulatorium Rennweg, Wien, Austria
A Trial of the ALK Grass Tablet in Subjects With Hayfever
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2013-01-29
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 634
- Registration Number
- NCT00227279
- Locations
- 🇩🇰
Lungemedicinsk Forskningsafdeling, Aarhus Kommunehospital, Aarhus C, Denmark
© Copyright 2024. All Rights Reserved by MedPath